Long-acting combination of cabotegravir plus rilpivirine: a picture of potential eligible HIV-positive individuals from the Italian ARCA cohort

被引：0
|
作者：
Cervo, A. [1 ]
Russo, A. [2 ]
Di Carlo, D. [3 ]
De Vito, A. [4 ]
Fabeni, L. [5 ]
D'Anna, S. [6 ]
Duca, L. [6 ]
Colpani, A.
Fois, M.
Zauli, B.
Mancarella, G. [7 ]
Carraro, A. [7 ]
Bezenchek, A. [8 ]
Cozzi-Lepri, A. [9 ]
Santoro, M. [6 ]
机构：
[1] Univ Hosp Modena, Infect Dis Clin, Modena, Italy
[2] Univ Campania Luigi Vanvitelli, Dept Mental Hlth, Infect Dis Unit, Naples, Italy
[3] Univ Milan, Dept Biomed Clin Sci L Sacco, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, Milan, Italy
[4] Univ Sassari, Dept Med Surg & Expt Sci, Unit Infect Dis, Sassari, Italy
[5] L Spallanzani Natl Inst Infect Dis, Rome, Italy
[6] Tor Vergata Univ Rome, Rome, Italy
[7] Sapienza Univ Rome Polo Pontino, Unit Infect Dis, Latina, Italy
[8] InformaPRO SRL, EuResist Network GEIE, Rome, Italy
[9] Inst Global Hlth, Ctr Clin Res Epidemiol Modelling & Evaluat, London, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P096
引用
收藏
页码：95 / 97
页数：3
相关论文
共 50 条
  • [31] Perceptions of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) from patients in the CAB plus RPV Implementation Study in European Locations (CARISEL)
    Lutz, T.
    Jeanmaire, E.
    Portilla, J.
    Scherzer, J.
    Trehan, R.
    Pascual-Bernaldez, M.
    DeMoor, R.
    Ait-Khaled, M.
    Hadi, M.
    Anand, S.
    Low, E.
    Czarnogorski, M.
    Gutner, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 117 - 118
  • [32] Perceptions of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) from patients in the CAB plus RPV implementation study in European locations (CARISEL)
    Lutz, Thomas
    Jeanmaire, Eliette
    Portilla, Joaquin
    Scherzer, Jenny
    Trehan, Rekha
    Pascaul-Bernaldez, Miguel
    DeMoor, Rebecca
    Ait-Khaled, Mounir
    Hadi, Monica
    Anand, Savita Bakhshi
    Low, Emma L.
    Czarnogorski, Maggie
    Gutner, Cassidy A.
    Neumann, Jeanette
    HIV MEDICINE, 2023, 24 : 20 - 21
  • [33] Letter to the Editor: Real-Life Experience of Long-Acting Cabotegravir-Rilpivirine Combination in a Person Living with HIV with Detectable Viremia: A Case Report
    Ciccullo, Arturo
    Iannone, Valentina
    Lombardi, Francesca
    Borghetti, Alberto
    Di Giambenedetto, Simona
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (10) : 555 - 556
  • [34] Perspectives on the acceptability, appropriateness, feasibility, barriers, and facilitators from patients receiving cabotegravir plus rilpivirine long-acting injectable treatment (CAB plus RPV LA): interim results from the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL)
    Hocqueloux, L.
    Gutner, C.
    DeMoor, R.
    Gill, M.
    Trehan, R.
    D'Amico, R.
    Tomkins, S.
    Schroeder, M.
    Bontempo, G.
    Ait-Khaled, M.
    Hadi, M.
    Anand, S. Bakhshi
    Low, E. L.
    Jeanmaire, E.
    Crusells Canales, M.
    Vandekerckhove, L.
    Bonnet, F.
    Olalla Sierra, J.
    Czarnogorski, M.
    HIV MEDICINE, 2021, 22 : 99 - 99
  • [35] Implementation of cabotegravir and rilpivirine long-acting (CAB plus RPV LA): primary results from the CAB plus RPV Implementation Study in European Locations (CARISEL)
    Van Welzen, B.
    Vandekerckhove, L.
    Jonsson-Oldenbuettel, C.
    Hocqueloux, L.
    Ait-Khaled, M.
    Bontempo, G.
    DeMoor, R.
    Scherzer, J.
    D'Amico, R.
    Barnes, N.
    Hadi, M.
    Low, E.
    Anand, S.
    Czarnogorski, M.
    Gutner, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 71 - 72
  • [36] Real-life effectiveness, safety and acceptance of long-acting cabotegravir-rilpivirine: results from a large single-centre cohort
    Gonzalez-Cordon, Ana
    Laguno, Montserrat
    Berrocal, Leire
    Martinez-Rebollar, Maria
    Torres, Berta
    Chivite, Ivan
    Inciarte, Alexy
    Arreba, Paula
    Ambrosioni, Juan
    Foncillas, Alberto
    de la Mora, Lorena
    Luis Blanco-Arevalo, Jose
    Calvo, Julia
    Martinez, Esteban
    Sempere, Abiu
    Miro, Jose M.
    Llobet, Roger
    de lazzari, Elisa
    Mallolas, Josep
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 88 - 89
  • [37] Favorable Virological Outcome, Characteristics of Injection Site Reactions, Decrease in Renal Function Biomarkers in Asian People with HIV Receiving Long-Acting Cabotegravir Plus Rilpivirine
    Adachi, Eisuke
    Saito, Makoto
    Otani, Amato
    Koga, Michiko
    Yotsuyanagi, Hiroshi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (04) : 216 - 222
  • [38] Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort
    Jongen, Vita W.
    Wit, Ferdinand W. N. M.
    Boyd, Anders
    van Eeden, Arne
    Brouwer, Annemarie E.
    Soetekouw, Robert
    El Moussaoui, Rachida
    Stalenhoef, Janneke
    Sigaloff, Kim C. E.
    Mudrikova, Tatiana
    Gisolf, Jet
    Burger, David
    Wensing, Annemarie M. J.
    van der Valk, Marc
    LANCET HIV, 2025, 12 (01): : e40 - e50
  • [39] POTENTIAL HEALTHCARE RESOURCE USE AND ASSOCIATED COSTS OF EVERY 2-MONTHS INJECTABLE CABOTEGRAVIR plus RILPIVIRINE LONG-ACTING IMPLEMENTATION IN THE SPANISH NHS VS DAILY ORAL HIV TREATMENTS
    Vallejo-Aparicio, L. A.
    Neches, V
    Hernandez Novoa, B.
    Casado, G.
    Jodar, F.
    Pinel, M.
    Callejo-Velasco, D.
    VALUE IN HEALTH, 2022, 25 (12) : S129 - S130
  • [40] Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir plus Rilpivirine Long-Acting Into European Clinical Settings
    Jonsson-Oldenbuettel, Celia
    Ghosn, Jade
    van der Valk, Marc
    Florence, Eric
    Vera, Francisco
    De Wit, Stephane
    Rami, Agathe
    Bonnet, Fabrice
    Hocqueloux, Laurent
    Hove, Kai
    Ait-Khaled, Mounir
    DeMoor, Rebecca
    Bontempo, Gilda
    Latham, Christine L.
    Gutner, Cassidy A.
    Iyer, Supriya
    Gill, Martin
    Czarnogorski, Maggie
    D'Amico, Ronald
    van Wyk, Jean
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (05) : 472 - 480
12345